Clinical trial

Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents

Recruiting now · Not applicable · 1 countries · Registry ID NCT05394363

Recruiting nowNot applicableObservational

What this study is about

Generation Victoria (GenV) is a longitudinal, population-based study of Victorian children and their parents that will bring together data on a wide range of conditions ,exposures and outcomes. GenV blends study-collected, study-enhanced and linked data. It will be multi-purpose, supporting observational, interventional, health services and policy research within the same cohort. It is designed to address physical, mental and social issues experienced during childhood, as well as the antecedents of a wide range of diseases of ageing. It seeks to generate translatable evidence (prediction, prevention, treatments, services) to improve future wellbeing and reduce the future disease burden of children and adults. The GenV Cohort 2020s is open to all children born over a two-year period, and their parents, residing in the state of Victoria Australia. The GenV Cohort 2020s is preceded by an Advance Cohort of children born between 5 Dec 2020 and 3 October 2021, and their parents. This comprises all families recruited at GenV's Vanguard hospital (Joan Kirner Women's and Children's) and at birthing hospitals throughout Victoria as GenV scaled up to commence recruiting for the GenV Cohort 2020s. The Advance Cohort have ongoing and full participation in GenV for their lifetime unless they withdraw but may have less complete data and biosamples.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age1 Day to Not listed

SexAll

Healthy volunteersAccepted

ConditionMental Health, Child Wellbeing, Infant Health, Child Health, Reproductive Health, Healthy Aging, Health Equity, Quality of Life, Social Determinants of Health, Environmental Exposure, Genetics, Cognition, Learning, Child Development, Congenital Abnormalities, Disability, Injuries, Communicable Diseases, Noncommunicable Diseases, Physical Fitness, Diet, Obesity, Allergy and Immunology, Inflammation, Intergenerational Relations

Full registry criteria

Inclusion Criteria (Children): * Birth date between 4th October 2021 and 3rd October 2023 * Live at the time of recruitment * Residing in Victoria at the time of recruitment * Has a legally acceptable representative capable of understanding the informed consent document and providing consent on the child's behalf, who provides a signed and dated informed consent form (e.g. a parent/guardian) Inclusion Criteria (Adults): * Be a parent or guardian of a child who meets the eligibility criteria above * Provide a signed and dated informed consent form or have a legally acceptable representative capable of understanding the informed consent document and providing consent on the participant's behalf. Exclusion criteria: * Children who are deceased at the time of recruitment (i.e. still born or died after birth) and their parents/guardians * Families unable to provide informed consent in any of the languages available

Treatments and study arms

The registry does not list a named intervention.

Primary outcomes

Number of parents and children enrolled in the GenV Cohort 2020sPoint of consent until study completion (up to 10 years)

Assessed by analysis of records in the study-specific Participant Relationship Management System (PRMS)

Number of participants with complete data collection at each wavePoint of consent until study completion (up to 10 years)

Assessed by analysis of records in the study-specific Participant Relationship Management System (PRMS), e-Consent platform and GenV data repository

Number of participants with successful data linkage at each wavePoint of consent until study completion (up to 10 years)

Assessed by analysis of records in the study-specific Participant Relationship Management System (PRMS), e-Consent platform and GenV data repository

Number of participants with the targeted biosamples received at each wavePoint of consent until study completion (up to 10 years)

Assessed by analysis of records in the study-specific Participant Relationship Management System (PRMS), e-Consent platform and GenV Laboratory Information Management System (LIMS)

Study locations

1 locations were listed when this page was built. The first 40 are shown.

Murdoch Children's Research Institute🇦🇺 Parkville, Victoria, Australia

Open map

GenV InfolineContact

Email · Call 1800 436 888